ipscell.com
Upcoming Right-To-Try debate: NYU's Roxland and Goldwater's Sandefur - The Niche
Should patients have the Right To Try experimental therapies that could be unsafe and ineffective? What if those patients have a terminal illness and no reasonable prospects of being helpful to conventional medicine? Doesn’t it make perfect sense to let them try a risky approach if they want to do so? On the other hand, … Upcoming Right-To-Try debate: NYU’s Roxland and Goldwater’s Sandefur Read More »
Professor Paul Knoepfler, Ph.D.